Systematic adjudication of myocardial infarction end-points in an international clinical trial

被引：0
|
作者：
Kenneth W Mahaffey
Robert A Harrington
Martijn Akkerhuis
Neal S Kleiman
Lisa G Berdan
Brian S Crenshaw
Barbara E Tardiff
Christopher B Granger
Ingrid DeJong
Manju Bhapkar
Petr Widimsky
Ramón Corbalon
Kerry L Lee
Jaap W Deckers
Maarten L Simoons
Eric J Topol
Robert M Califf
机构：
[1] Duke Clinical Research Institute,
[2] Thoraxcenter,undefined
[3] Erasmus University,undefined
[4] Baylor College of Medicine and the Methodist Hospital,undefined
[5] University Hospital Vinohrady,undefined
[6] University Catolica,undefined
[7] The Cleveland Clinic Foundation,undefined
来源：
Trials | / 2卷 / 4期
关键词：
acute coronary syndromes; adjudication; clinical events committee; clinical trials; myocardial infarction;
D O I：
10.1186/cvm-2-4-180
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Systematic adjudication of myocardial infarction end-points in an international clinical trial
    Mahaffey, KW
    Harrington, RA
    Akkerhuis, M
    Kleiman, NS
    Berdan, LG
    Crenshaw, BS
    Tardiff, BE
    Granger, CB
    DeJong, I
    Bhapkar, M
    Widimsky, P
    Corbalon, R
    Lee, KL
    Deckers, JW
    Simoons, ML
    Topol, EJ
    Califf, RM
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (04): : 180 - 186
  • [2] A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
    Crichton, Megan L.
    Aliberti, Stefano
    Chalmers, James D.
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (151):
  • [3] Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trial
    Mahaffey, KW
    Roe, MT
    Dyke, CK
    Newby, LK
    Kleiman, NS
    Connolly, P
    Berdan, LG
    Sparapani, R
    Lee, KL
    Armstrong, PW
    Topol, EJ
    Califf, RM
    Harrington, RA
    AMERICAN HEART JOURNAL, 2002, 143 (02) : 242 - 248
  • [4] DESIGN OF CLINICAL-TRIAL - END-POINTS - CONSIDERATIONS IN THE SELECTION OF END-POINTS FOR AIDS CLINICAL-TRIALS
    AMATO, DA
    LAGAKOS, SW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S64 - S68
  • [5] CLINICAL SURROGATE END-POINTS
    Palmeri, Sergio
    EJC SUPPLEMENTS, 2007, 5 (09): : 44 - 45
  • [6] USE OF COMPOSITE END-POINTS IN THROMBOLYSIS TRIALS OF ACUTE MYOCARDIAL-INFARCTION
    BRAUNWALD, E
    CANNON, CP
    MCCABE, CH
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (19): : G3 - G12
  • [7] AN OVERVIEW OF THE EFFECT OF INTRAVENOUS HEPARIN ON CLINICAL END-POINTS FOLLOWING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    GRANGER, CB
    OCONNOR, CM
    BLEICH, SD
    COL, JJ
    KEELER, GP
    OHMAN, EM
    CIRCULATION, 1992, 86 (04) : 259 - 259
  • [8] Editorial: international consensus in clinical trial end-points in ulcerative colitis - clarity or just a step in clearing the fog?
    Christensen, B.
    Sparrow, M. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1274 - 1275
  • [9] END-POINTS IN PERIODONTAL CLINICAL-TRIALS
    HUJOEL, PP
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 164 - 164
  • [10] Clinical trials: types, design, and end-points
    Seibold, JR
    CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (06) : 512 - 515
12345